Animi-3 is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Pbm Pharmaceuticals, Inc. The primary component is Folic Acid; Cholecalciferol; Pyridoxine Hydrochloride; Cyanocobalamin; Omega-3 Fatty Acids; Doconexent; Icosapent; Soy Sterol.
| Product ID | 66213-543_5e947d00-9af4-4632-bca3-e8b30ce39100 | 
| NDC | 66213-543 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Animi-3 | 
| Generic Name | Folic Acid, Cholecalciferol, Pyridoxine Hydrochloride, Cyanocobalamin, Omega-3 Fatty Acids, Doconexent, Icosapent, Phytosterols | 
| Dosage Form | Capsule | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2011-06-01 | 
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER | 
| Labeler Name | PBM Pharmaceuticals, Inc | 
| Substance Name | FOLIC ACID; CHOLECALCIFEROL; PYRIDOXINE HYDROCHLORIDE; CYANOCOBALAMIN; OMEGA-3 FATTY ACIDS; DOCONEXENT; ICOSAPENT; SOY STEROL | 
| Active Ingredient Strength | 1 mg/1; [iU]/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1 | 
| Pharm Classes | Fatty Acids, Omega-3 [CS],Omega-3 Fatty Acid [EPC],Vitamin D [CS],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2019-12-31 | 
| Marketing Start Date | 2011-06-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | unapproved drug other | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2011-06-01 | 
| Inactivation Date | 2020-01-31 | 
| Ingredient | Strength | 
|---|---|
| FOLIC ACID | 1 mg/1 | 
| SPL SET ID: | 469db782-ba46-485d-b5b7-1ef32805bdb7 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  ANIMI-3  76574844  2940637 Live/Registered | PBM Pharmaceuticals, Inc. 2004-02-06 | 
|  ANIMI-3  76548928  2940632 Live/Registered | PBM Pharmaceuticals, Inc. 2003-09-11 |